Bioactive molecules of Taenia solium metacestode, a causative agent of neurocysticercosis

Expert Review of Proteomics

Volumn 7, Issue 5, 2010, Pages 691-707

  Bae, Young An ^a   Xue, Yanping ^b   Lee, Eung Goo ^a   Kim, Seon Hee ^a   Kong, Yoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Beijing Tropical Medicine Research Institute   (China)

Author keywords

bioactive molecules; diagnostic biomarkers; immunoproteomics; neurocysticercosis; Taenia solium metacestode

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANNEXIN; BIOLOGICAL MARKER; CALRETICULIN; FATTY ACID BINDING PROTEIN; FIBRONECTIN; GLUCOSE TRANSPORTER; GLUTATHIONE TRANSFERASE; HELMINTH PROTEIN; HISTAMINE RECEPTOR; METALLOPROTEINASE; NEURONAL NITRIC OXIDE SYNTHASE; PARAMYOSIN; PEROXIREDOXIN; PRAZIQUANTEL; PREALBUMIN; PROGESTERONE RECEPTOR; PROSTAGLANDIN D SYNTHASE; PROTEIN; SUPEROXIDE DISMUTASE; TRIOSEPHOSPHATE ISOMERASE; VOLTAGE GATED CALCIUM CHANNEL;

DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; IMMUNOMODULATION; METACESTODE; NEUROCYSTICERCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOSPHERE; PHYLOGENY; REVIEW; SERODIAGNOSIS; TAENIA SOLIUM; UNINDEXED SEQUENCE;

ANIMALS; ANTIBODIES, HELMINTH; HELMINTH PROTEINS; HUMANS; NEUROCYSTICERCOSIS; TAENIA SOLIUM;

TAENIA SOLIUM;

EID: 77958578557     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.10.72     Document Type: Review

References (105)

1. Liu YM, Bair MJ, Chang WH, Lin SC, Chan YJ. Acute pancreatitis caused by tapeworm in the biliary tract. Am. J. Trop. Med. Hyg 73, 377-380 (2005).
2. Gilman RH, Del Brutto OH, Garcia HH, Martinez M. The Cysticercosis Working Group in Peru. Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. Neurology 55, 1062 (2000).
3. Verastegui M, Gilman RH, Garcia HH et al. Prevalence of antibodies to unique Taenia solium oncosphere antigens in taeniasis and human and porcine cysticercosis. Am. J. Trop. Med. Hyg. 69, 438-444 (2003).
4. Lescano AG, Garcia HH, Gilman RH et al. Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am. J. Trop. Med. Hyg 76, 376-383 (2007).
5. Lescano AG, Garcia HH, Gilman RH et al. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl. Trop. Dis. 3, e371 (2009).
6. Mahanty S, Garcia HH; The Cysticercosis Working Group in Perú. Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog. Neurobiol. 91(2), 172-184 (2010).
7. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classifcation based on active and inactive forms: a study of 753 cases. Arch. Intern. Med. 145, 442-445 (1985).
8. Del Brutto OH, Sotelo J, Roman GC. Neurocysticercosis: A Clinical Handbook. Del Brutto OH, Sotelo J, Roman GC (Eds). Swets and Zeitlinger Publishers, Lisse, The Netherlands (1998).
9. Chung JY, Bahk YY, Huh S, Kang SY, Kong Y, Cho SY A recombinant 10-kDa protein of Taenia solium metacestodes specifc to active neurocysticercosis. J. Infect. Dis. 180, 1307-1315 (1999).
10. Meyer A, Dua T, Ma J, Saxena A, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. WHO Bulletin 88, 260-266 (2010).
11. Gonzalez AE, Cama V, Gilman RH et al. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am. J. Trop. Med. Hyg 43, 94-99 (1990).
12. Onah DN, Chiejina SN. Taenia solium cysticercosis and human taeniasis in the Nsukka area of Enugu State, Nigeria. Ann. Trop. Med. Parasitol. 89, 399-407 (1995).
13. Phiri IK, Ngowi H, Afonso S et al. The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop. 87, 13-23 (2003).
14. White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Ann. Rev. Med. 51, 187-206 (2000).
15. Garcia HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am. J. Trop. Med. Hyg. 72, 3-9 (2005).
16. Singhi P, Singhi S. Neurocysticercosis in children. Indian J. Pediatr. 76, 537-545 (2009).
17. Sciutto E, Fragoso G, Fleury A et al. Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes Infect. 2, 1875-1890 (2000).
18. Sotelo J, Del Brutto OH. Brain cysticercosis. Arch. Med. Res. 31, 3-14 (2000).
19. Esquivel A, Diaz-Otero F, Gimenez-Roldan S. Growing frequency of neurocysticercosis in Madrid (Spain). Neurologia 20, 116-120 (2005).
20. Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from cysticercosis, United States. Emerg. Infect. Dis. 13, 230-235 (2007).
21. Chang KH, Han MH. MRI of CNS parasitic diseases. J. Magn. Reson. Imaging 8, 297-307 (1998).
22. Patel R, Jha S, Yadav RK. Pleomorphism of the clinical manifestations of neurocysticercosis. Trans. R. Soc. Trop. Med. Hyg 100, 134-141 (2006).
23. Kim SI, Kang SY, Cho SY, Hwang ES, Cha CY Purifcation of cystic fuid antigen of Taenia solium metacestodes by affnity chromatography using monoclonal antibody and its antigenic characterization. Korean J. Parasitol. 24, 145-158 (1986).
24. Cho SY, Kim SI, Kang SY, Kong Y Biochemical properties of a purifed protein in cystic fuid of Taenia solium metacestodes. Korean J. Parasitol. 26, 87-94 (1988).
25. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J. Infect. Dis. 159, 50-59 (1989).
26. Yang HJ, Chung JY, Yun DH et al. Immunoblot ana lysis of a 10 kDa antigen in cyst fuid of Taenia solium metacestodes. Parasite Immunol. 20, 483-488 (1998).
27. Ko RC, Ng TF. Specifcity of isoelectric focusing-purifed antigens in the diagnosis of human cysticercosis. Parasitol Res. 84, 565-969 (1998).
28. Ito A, Plancarte A, Ma L et al. Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. Am. J. Trop. Med. Hyg 59, 291-294 (1998).
29. Sako Y, Nakao M, Ikejima T, Piao XZ, Nakaya K, Ito A. Molecular characterization and diagnostic value of Taenia solium low-molecular-weight antigen genes. J. Clin. Microbiol. 38, 4439-4444 (2000).
30. Sato MO, Yamasaki H, Sako Y et al. Evaluation of tongue inspection and serology for diagnosis of Taenia solium cysticercosis in swine. Vet. Parasitol. 111, 309-322 (2003).
31. Hancock K, Khan A, Williams FB et al. Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J. Clin. Microbiol. 41, 2577-2586 (2003).
32. Lee EG, Bae YA, Jeong YT et al. Proteomic ana lysis of a 120 kDa protein complex in cyst fuid of Taenia solium metacestode and preliminary evaluation of its value for the serodiagnosis of neurocysticercosis. Parasitology 131, 867-879 (2005).
33. Scheel CM, Khan A, Hancock K et al. Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats. Am. J. Trop. Med. Hyg 73, 771-776 (2005).
34. Sako MO, Sako Y, Nakao M, Yamasaki H, Nakaya K, Ito A. Evaluation of purifed Taenia solium glycoproteins and recombinant antigens in the serologic detection of human and swine cysticercosis. J. Infect. Dis. 194, 1783-1790 (2006).
35. Bueno EC, Scheel CM, Vaz AJ et al. Application of synthetic 8-kD and recombinant GP50 antigens in the diagnosis of neurocysticercosis by enzyme-linked immunosorbent assay Am. J. Trop. Med. Hyg. 72, 278-283 (2005).
36. Lee EG, Kim SH, Bae YA et al. A hydrophobic ligand binding protein of the Taenia solium metacestode mediates uptake of the host lipid: implication for the maintenance of parasitic cellular homeostasis. Proteomics 7, 4016-4030 (2007).
37. Ferrer E, Bonay P, Foster-Cuevas M et al. Molecular cloning and characterisation of Ts8B1, Ts8B2 and Ts8B3, three new members of the Taenia solium metacestode 8 kDa diagnostic antigen family Mol. Biochem. Parasitol. 152, 90-100 (2007).
38. Bae YA, Jeong YT, Chung JY et al. A recombinant chimeric antigen toward a standardized serodiagnosis of Taenia solium neurocysticercosis. Proteomics Clin. Appl. 2, 1596-1610 (2008).
39. Deckers N, Dorny P. Immunodiagnosis of Taenia solium taeniosis/ cysticercosis. Trends Parasitol. 26, 137-144 (2010).
40. Sikasunge CS, Phiri IK, Johansen MV, Willingham AL 3rd, Leifsson PS. Host-cell apoptosis in Taenia solium-induced brain granulomas in naturally infected pigs. Parasitology 135, 1237-1242 (2008).
41. Alvarez JI, Rivera J, Teale JM. Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategies. PLoS Negl. Trop. Dis. 9, e218 (2008).
42. Vaca-Paniagua F, Torres-Rivera A, Parra-Unda R, Landa A. Taenia solium: antioxidant metabolism enzymes as targets for cestocidal drugs and vaccines. Curr. Top. Med. Chem. 8, 393-399 (2008).
43. Lee EG, Lee MY, Chung JY et al. Feasibility of baculovirus-expressed recombinant 10-kDa antigen in the serodiagnosis of Taenia solium neurocysticercosis. Trans. R. Soc. Trop. Med. Hyg 99, 919-926 (2005).
44. Serpa JA, Yancey LS, White AC Jr. Advances in the diagnosis and management of neurocysticercosis. Expert Rev. Anti Infect. Ther. 4, 1051-1061 (2006).
45. Greene RM, Hancock K, Wilkins PP, Tsang VC. Taenia solium: molecular cloning and serologic evaluation of 14-and 18-kDa related, diagnostic antigens. J. Parasitol. 86, 1001-1007 (2000).
46. Hancock K, Pattabhi S, Greene RM et al. Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol. Biochem. Parasitol. 133, 115-124 (2004).
47. Hancock K, Pattabhi S, Whitfeld FW et al. Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol. Biochem. Parasitol. 147, 109-117 (2006).
48. Restrepo BI, Obregon-Henao A, Mesa M et al. Characterisation of the carbohydrate components of Taenia solium metacestode glycoprotein antigens. Int. J. Parasitol 30, 689-696 (2000).
49. Obregón-Henao A, Gil DL, Gómez DI, Sanzón F, Teale JM, Restrepo BI. The role of N-linked carbohydrates in the antigenicity of Taenia solium metacestode glycoproteins of 12, 16 and 18 kD. Mol. Biochem. Parasitol. 114, 209-215 (2001).
50. Villota GE, Gomez DI, Volcy M et al. Similar diagnostic performance for neurocysticercosis of three glycoprotein preparations from Taenia solium metacestodes. Am. J. Trop. Med. Hyg. 68, 276-280 (2003).
51. Deckers N, Saerens D, Kanobana K et al. Nanobodies, a promising tool for species-specifc diagnosis of Taenia solium cysticercosis. Int. J. Parasitol. 39, 625-633(2009).
52. Greene RM, Wilkins PP, Tsang VC. Diagnostic glycoproteins of Taenia solium cysts share homologous 14-and 18-kDa subunits. Mol. Biochem. Parasitol. 99, 257-261 (1999).
53. Haslam SM, Restrepo BI, Obergon-Henao A, Teale JM, Morris HR, Dell A. Structural characterization of the N-linked glycans from Taenia solium metacestodes. Mol. Biochem. Parasitol. 126, 103-107 (2003).
54. Handali S, Klarman M, Gaspard AN et al. Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin. Vaccine Immunol. 17, 68-72 (2010).
55. Cho SY, Kong Y, Kim SI, Kang SY Measurement of 150 kDa protein of Taenia solium metacestodes by antibody-sandwich ELISA in cerebrospinal fuid of neurocysticercosis patients. Korean J. Parasitol. 30, 299-307 (1992).
56. Gao YJ, Yan HL, Ding FX, Lu YM, Sun SH. Annexin B1 at the host-parasite interface of the Taenia solium cysticercus: secreted and associated with infammatory reaction. Acta Trop. 101, 192-199 (2007).
57. Yan HL, Xue G, Mei Q, Ding FX, Wang YZ, Sun SH. Calcium-dependent proapoptotic effect of Taenia solium metacestodes annexin B1 on human eosinophils: a novel strategy to prevent host immune response. Int. J. Biochem. Cell. Biol. 40, 2151-2163 (2008).
58. Vibanco-Perez N, Jimenez L, Merchant MT, Landa A. Characterization of glutathione-S transferase of Taenia solium. J. Parasitol. 85, 448-453 (1999).
59. Vibanco-Perez N, Jimenez L, Mendoza-Hernandez G, Landa A. Characterization of a recombinant μ-class glutathione S-transferase from Taenia solium. Parasitol. Res. 88, 398-404 (2002).
60. Plancarte A, Rendon JL, Landa A. Purifcation, characterization and kinetic properties of the Taenia solium glutathione S-transferase isoform 26.5 kDa. Parasitol. Res. 93, 137-144 (2004).
61. Nguyen HA, Bae YA, Lee EG et al. A novel σ-like glutathione transferase of Taenia solium metacestode. Int. J. Parasitol. 40, 1097-1106 (2010).
62. Nava G, Robert L, Plancarte A. Characterization of Taenia solium cysticerci microsomal glutathione S-transferase activity. Parasitol. Res. 101, 1373-1381 (2007).
63. Castellanos-González A, Jimenez L, Landa A. Cloning, production and characterisation of a recombinant Cu/Zn superoxide dismutase from Taenia solium. Int. J. Parasitol. 32, 1175-1182 (2002).
64. Molina-López J, Jiménez L, Ochoa-Sánchez A, Landa A. Molecular cloning and characterization of a 2-Cys peroxiredoxin from Taenia solium. J. Parasitol. 92, 796-802 (2006).
65. Vaca-Paniagua F, Parra-Unda R, Landa A. Characterization of one typical 2-Cys peroxiredoxin gene of Taenia solium and Taenia crassiceps. Parasitol. Res. 105, 781-787 (2009).
66. Rodríguez-Contreras D, Skelly PJ, Landa A, Shoemaker CB, Laclette JP. Molecular and functional characterization and tissue localization of 2 glucose transporter homologues (TGTP1 and TGTP2) from the tapeworm Taenia solium. Parasitology 117, 579-588 (1998).
67. Montero E, Gonzalez LM, Bonay P et al. Taenia solium: identifcation and preliminary characterization of a lipid binding protein with homology to the SEC14 catalytic domain. Exp. Parasitol. 116, 191-200 (2007).
68. Plancarte A, Flisser A, Gauci CG, Lightowlers MW. Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens. Int. J. Parasitol. 29, 643-647 (1999).
69. Lightowlers MW, Gauci CG, Chow C et al. Molecular and genetic characterisation of the host-protective oncosphere antigens of taeniid cestode parasites. Int. J. Parasitol. 33, 1207-1217 (2003).
70. Mayta H, Hancock K, Levine MZ et al. Characterization of a novel Taenia solium oncosphere antigen. Mol. Biochem. Parasitol. 156, 154-161 (2007).
71. Flisser A, Gauci CG, Zoli A et al. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect. Immun. 72, 5292-5297 (2004).
72. Gonzalez AE, Gauci CG, Barber D et al. Vaccination of pigs to control human neurocysticercosis. Am. J. Trop. Med. Hyg 72, 837-839 (2005).
73. Zheng Y, Cai X, Zhang D, Jing Z. Genetic variability of the 45W gene family between Chinese and Mexican Taenia solium. Am. J. Trop. Med. Hyg. 78, 946-948 (2008).
74. Assana E, Kyngdon CT, Gauci CG et al. Elimination of Taenia solium transmission to pigs in a feld trial of the TSOL18 vaccine in Cameroon. Int. J. Parasitol. 40, 515-519 (2010).
75. Marshall W, Lightowlers MW. Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. Int. J. Parasitol. DOI: 10.1016/j.ijpara.2010.05. 001 (2010) (Epub ahead of print).
76. Kyngdon CT, Gauci CG, Rolfe RA et al. In vitro oncosphere-killing assays to determine immunity to the larvae of Taenia pisiformis, Taenia ovis, Taenia saginata, and Taenia solium. J. Parasitol. 92, 273-281 (2006).
77. Verastegui M, Gilman RH, Garcia HH et al. Prevalence of antibodies to unique Taenia solium oncosphere antigens in taeniasis and human and porcine cysticercosis. Am. J. Trop. Med. Hyg. 69, 438-444 (2003).
78. Guo A, Jin Z, Zheng Y et al. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination. Vaccine 25, 170-175 (2007).
79. Sciutto E, Rosas G, Hernández M et al. Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine. Vaccine 25, 1368-1378 (2007).
80. Santovanez SJ, Hernandez-Gonzalez A, Chile N et al. Proteomic study of activated Taenia solium oncosphere. Mol. Biochem. Parasitol. 171, 32-39 (2010).
81. Flisser A, Woodhouse E, Larralde C. Human cysticercosis: antigens, antibodies and non-responders. Clin. Exp. Immunol. 39, 27-37 (1980).
82. Landa A, Laclette JP, Nicholson-Weller A, Shoemaker CB. cDNA cloning and recombinant expression of collagen-binding and complement inhibitor activity of Taenia solium paramyosin (AgB). Mol. Biochem. Parasitol. 60, 343-347 (1993).
83. Laclette JP, Shoemaker CB, Richter D et al. Paramyosin inhibits complement C1. J. Immunol. 148, 124-128 (1992).
84. Morales J, Velasco T, Tovar V et al. Castration and pregnancy of rural pigs signifcantly increase the prevalence of naturally acquired Taenia solium cysticercosis. Vet. Parasitol. 108, 41-48 (2002).
85. Escobedo G, Camacho-Arroyo I, Hernández-Hernández OT, Ostoa-Saloma P, García-Varela M, Morales-Montor J. Progesterone induces scolex evagination of the human parasite Taenia solium: evolutionary implications to the host-parasite relationship. J. Biomed. Biotechnol DOI: 10.1155/2010/591079 (2010) (Epub ahead of print).
86. White AC Jr, Molinari JL, Pillai AV, Rege AA. Detection and preliminary characterization of Taenia solium metacestode proteases. J. Parasitol, 78, 281-287 (1992).
87. Molinari JL, Mejia H, White AC Jr et al. Taenia solium: a cysteine protease secreted by metacestodes depletes human CD4 lymphocytes in vitro. Exp. Parasitol. 94, 133-142 (2000).
88. + T-cells. Parasitol. Res. 92, 197-204 (2004).
89. Baig S, Damian RT, Molinari JL et al. Purifcation and characterization of a metacestode cysteine proteinase from Taenia solium involved in the breakdown of human IgG. Parasitology 131, 411-416 (2005).
90. Solano S, Cortés IM, Copitin NI, Tato P, Molinari JL. Lymphocyte apoptosis in the infammatory reaction around Taenia solium metacestodes in porcine cysticercosis. Vet. Parasitol. 140, 171-176 (2006).
91. Li AH, Moon SU, Park YK et al. Identifcation and characterization of a cathepsin L-like cysteine protease from Taenia solium metacestode. Vet. Parasitol. 141, 251-259 (2006).
92. Zimic M, Pajuelo M, Rueda D et al. Utility of a protein fraction with cathepsin L-like activity purifed from cysticercus fuid of Taenia solium in the diagnosis of human cysticercosis. Am. J. Trop. Med. Hyg 80, 964-970 (2009).
93. Cai GB, Bae YA, Kim SH et al. A membrane-associated metalloprotease of Taenia solium metacestode structurally related to the FACE-1/Ste24p protease family Int. J. Parasitol. 36, 925-935 (2006).
94. Mendlovic F, Carrillo-Farga J, Torres J, Lactle JP, Flisser A. Differential expression of calreticulin in developmental stages of Taenia solium. J. Parasitol. 92, 789-795 (2006).
95. Mendlovic F, Ostoa-Saloma P, Solís CF, Martínez-Ocaña J, Flisser A, Laclette JP. Cloning, characterization, and functional expression of Taenia solium calreticulin. J. Parasitol. 90, 891-893 (2004).
96. Kim SH, Chung JY, Bae YA et al. Functional identifcation of a protein inhibitor of neuronal nitric oxide synthase of Taenia solium metacestode. Mol. Biochem. Parasitol. 151, 41-51 (2007).
97. +-ATPase α-subunit from Taenia solium (TNaK1α). Mol. Biochem. Parasitol. 138, 79-82 (2004).
98. Jiménez L, Vibanco-Pérez N, Navarro L, Landa A. Cloning, expression and characterisation of a recombinant triosephosphate isomerase from Taenia solium. Int. J. Parasitol. 30, 1007-1012 (2000).
99. Jeziorski MC, Greenberg RM. Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int. J. Parasitol. 36, 625-632 (2006).
100. Garcia HH, Pretell EJ, Gilman RH et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N. Engl. J. Med. 350, 249-258 (2004).
101. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J. Neurol. Sci. 142, 1-6 (1996).
102. McCormick GF. Cysticercosis-review of 230 patients. Bull. Clin. Neurosci. 50, 76-101 (1985).
103. Chung JY, Kho WG, Hwang SY et al. Molecular determination of the origin of acephalic cysticercus. Parasitology 130, 239-246 (2005).
104. Hauptman JS, Hinrichs C, Mele C, Lee HJ. Radiologic manifestations of intraventricular and subarachnoid racemose neurocysticercosis. Emerg. Radiol. 11, 153-157 (2005).
105. Torgovnick J, Onouha A, Arsura E, Sethi NK, Sethi PK. Neuroimage: racemose neurocysticercosis. Clin. Neurol. Neurosurg 110, 97-98 (2008).